Laurent Chardonnet - Net Worth and Insider Trading
Laurent Chardonnet Net Worth
The estimated net worth of Laurent Chardonnet is at least $322,945 dollars as of 2024-05-03. Laurent Chardonnet is the CFO of Prelude Therapeutics Inc and owns about 42,165 shares of Prelude Therapeutics Inc (PRLD) stock worth over $168,660. Laurent Chardonnet is the Vice President and Treasurer of Incyte Corp and owns about 2,905 shares of Incyte Corp (INCY) stock worth over $154,226. Laurent Chardonnet is also the CFO of Axcella Health Inc and owns about 147 shares of Axcella Health Inc (AXLA) stock worth over $59. Details can be seen in Laurent Chardonnet's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Laurent Chardonnet has not made any transactions after 2023-05-23 and currently still holds the listed stock(s).
Transaction Summary of Laurent Chardonnet
Laurent Chardonnet Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laurent Chardonnet owns 3 companies in total, including Axcella Health Inc (AXLA) , Incyte Corp (INCY) , and Prelude Therapeutics Inc (PRLD) .
Click here to see the complete history of Laurent Chardonnet’s form 4 insider trades.
Insider Ownership Summary of Laurent Chardonnet
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AXLA | Axcella Health Inc | 2020-01-31 | Chief Financial Officer |
| INCY | Incyte Corp | 2015-03-30 | VP Finance and Treasurer |
| PRLD | Prelude Therapeutics Inc | 2023-05-23 | Chief Financial Officer |
Laurent Chardonnet Latest Holdings Summary
Laurent Chardonnet currently owns a total of 3 stocks. Among these stocks, Laurent Chardonnet owns 42,165 shares of Prelude Therapeutics Inc (PRLD) as of May 23, 2023, with a value of $168,660 and a weighting of 52.23%. Laurent Chardonnet owns 2,905 shares of Incyte Corp (INCY) as of March 30, 2015, with a value of $154,226 and a weighting of 47.76%. Laurent Chardonnet also owns 147 shares of Axcella Health Inc (AXLA) as of January 31, 2020, with a value of $59 and a weighting of 0.02%.
Latest Holdings of Laurent Chardonnet
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | 2023-05-23 | 42,165 | 4.00 | 168,660 |
| INCY | Incyte Corp | 2015-03-30 | 2,905 | 53.09 | 154,226 |
| AXLA | Axcella Health Inc | 2020-01-31 | 147 | 0.40 | 59 |
Holding Weightings of Laurent Chardonnet
Laurent Chardonnet Form 4 Trading Tracker
According to the SEC Form 4 filings, Laurent Chardonnet has made a total of 3 transactions in Prelude Therapeutics Inc (PRLD) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Prelude Therapeutics Inc is the acquisition of 5,000 shares on May 23, 2023, which cost Laurent Chardonnet around $27,500.
According to the SEC Form 4 filings, Laurent Chardonnet has made a total of 0 transactions in Incyte Corp (INCY) over the past 5 years. The most-recent trade in Incyte Corp is the sale of 113,776 shares on March 30, 2015, which brought Laurent Chardonnet around $11 Million.
According to the SEC Form 4 filings, Laurent Chardonnet has made a total of 2 transactions in Axcella Health Inc (AXLA) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Axcella Health Inc is the acquisition of 120 shares on January 31, 2020, which cost Laurent Chardonnet around $14,820.
Insider Trading History of Laurent Chardonnet
- 1
Laurent Chardonnet Trading Performance
GuruFocus tracks the stock performance after each of Laurent Chardonnet's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Laurent Chardonnet is 10.1%. GuruFocus also compares Laurent Chardonnet's trading performance to market benchmark return within the same time period. The performance of stocks bought by Laurent Chardonnet within 3 months outperforms 5 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Laurent Chardonnet's insider trading performs compared to the benchmark.
Performance of Laurent Chardonnet
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.2 | | | | | |
| Relative Return to S&P 500(%) | -0.54 | | | | | |
Laurent Chardonnet Ownership Network
Laurent Chardonnet Owned Company Details
What does Axcella Health Inc do?
Who are the key executives at Axcella Health Inc?
Laurent Chardonnet is the Chief Financial Officer of Axcella Health Inc. Other key executives at Axcella Health Inc include Senior Vice President & CIPO Paul Fehlner , director & President and CEO William Hinshaw , and 10 percent owner L.p. Fpa, .
Axcella Health Inc (AXLA) Insider Trades Summary
Over the past 18 months, Laurent Chardonnet made no insider transaction in Axcella Health Inc (AXLA). Other recent insider transactions involving Axcella Health Inc (AXLA) include a net sale of 5,221 shares made by Paul Fehlner ,
In summary, during the past 3 months, insiders sold 0 shares of Axcella Health Inc (AXLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 209 shares of Axcella Health Inc (AXLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 209 shares.
Axcella Health Inc (AXLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Axcella Health Inc Insider Transactions
Laurent Chardonnet Mailing Address
Above is the net worth, insider trading, and ownership report for Laurent Chardonnet. You might contact Laurent Chardonnet via mailing address: C/o Axcella Health Inc., 840 Memorial Drive, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
